Literature DB >> 24091810

Relationship between alveolar nitric oxide concentration in exhaled air and small airway function in COPD.

Tsunahiko Hirano1, Kazuto Matsunaga, Hisatoshi Sugiura, Yoshiaki Minakata, Akira Koarai, Keiichiro Akamatsu, Tomohiro Ichikawa, Kanako Furukawa, Masakazu Ichinose.   

Abstract

Nitrative stress is thought to be involved in the inflammatory process in COPD airways, and the alveolar nitric oxide concentration (CAlv) has been reported to be increased. However, the CAlv levels are also regulated by gas diffusion at alveolar sites. The aim of the study was to assess the relationship between the CAlv and pulmonary function in COPD patients, while taking into account the lung diffusion capacity. Twenty stable COPD patients (GOLD stage1/2/3/4 = 6/8/6/0) and 16 healthy subjects took part in this cross-sectional study. Fractional exhaled nitric oxide (FE(NO)), CAlv, and pulmonary functions were measured. Pulmonary function, including single nitrogen washout curve (dN2) and diffusion capacity for carbon monoxide (DL(CO)), was also evaluated in patients with COPD. The mean FE(NO) levels (20.7 ppb versus 16.3 ppb, p < 0.05) and the mean CAlv levels (6.4 ppb versus 4.2 ppb, p < 0.01) in COPD patients were significantly increased compared to those in HS. The CAlv level in COPD was significantly correlated with dN2, %DL(CO)/alveolar volume (VA). Using the standard entry method of multivariate analysis to adjust for dN2 and %DL(CO)/VA, dN2 (β = 0.54, p = 0.005) and %DL(CO)/VA (β = -0.44, p = 0.018) still showed significant correlations with the CAlv levels. These results suggest that the CAlv could be a useful marker for the small airway dysfunction in COPD. Airway inflammation, including excess nitric oxide generation in the peripheral airways, might be related to the pathophysiology of COPD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24091810     DOI: 10.1088/1752-7155/7/4/046002

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  8 in total

1.  Significance of alveolar nitric oxide concentration in the airway of patients with organizing pneumonia after allogeneic hematopoietic stem cell transplantation.

Authors:  Yasuko Kajimura; Yukinori Nakamura; Tsunahiko Hirano; Yoshinori Tanaka; Kaoru Yamamoto; Yoshihiro Tokunaga; Takahiro Sasaki; Keiji Oishi; Toshiaki Yujiri; Kazuto Matsunaga; Yukio Tanizawa
Journal:  Ann Hematol       Date:  2022-05-23       Impact factor: 4.030

2.  Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties.

Authors:  Anton Amann; Pawel Mochalski; Vera Ruzsanyi; Yoav Y Broza; Hossam Haick
Journal:  J Breath Res       Date:  2014-02-24       Impact factor: 3.262

3.  Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN).

Authors:  F Braido; N Scichilone; F Lavorini; O S Usmani; L Dubuske; L P Boulet; R Mosges; C Nunes; M Sanchez-Borges; I J Ansotegui; M Ebisawa; F Levi-Schaffer; L J Rosenwasser; J Bousquet; T Zuberbier; G Walter Canonica; A Cruz; A Yanez; A Yorgancioglu; D Deleanu; G Rodrigo; J Berstein; K Ohta; P Vichyanond; R Pawankar; S N Gonzalez-Diaz; S Nakajima; T Slavyanskaya; A Fink-Wagner; C Baez Loyola; D Ryan; G Passalacqua; J Celedon; J C Ivancevich; K Dobashi; M Zernotti; M Akdis; S Benjaponpitak; S Bonini; W Burks; L Caraballo; Z Awad El-Sayed; S Fineman; P Greenberger; E Hossny; J A Ortega-Martell; H Saito; M Tang; L Zhang
Journal:  World Allergy Organ J       Date:  2016-10-28       Impact factor: 4.084

Review 4.  Late-onset asthma: current perspectives.

Authors:  Tsunahiko Hirano; Kazuto Matsunaga
Journal:  J Asthma Allergy       Date:  2018-02-09

5.  Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis.

Authors:  Taizou Hirano; Shinya Ohkouchi; Naoki Tode; Makoto Kobayashi; Manabu Ono; Teruyuki Satoh; Yoichiro Mitsuishi; Akira Watanabe; Masao Tabata; Toshiya Irokawa; Hiromasa Ogawa; Hisatoshi Sugiura; Toshiaki Kikuchi; Keiichi Akasaka; Ryushi Tazawa; Yoshikazu Inoue; Koh Nakata; Hajime Kurosawa; Masakazu Ichinose
Journal:  ERJ Open Res       Date:  2018-03-23

6.  Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Zhiyu Lu; Weina Huang; Linfeng Wang; Ning Xu; Qunli Ding; Chao Cao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-30

7.  Clinical Utility of Central and Peripheral Airway Nitric Oxide in Aging Patients with Stable and Acute Exacerbated Chronic Obstructive Pulmonary Disease.

Authors:  Xiaodong Fan; Nian Zhao; Zhen Yu; Haoda Yu; Bo Yin; Lifei Zou; Yinying Zhao; Xiufen Qian; Xiaoyan Sai; Chu Qin; Congli Fu; Caixia Hu; Tingting Di; Yue Yang; Yan Wu; Tao Bian
Journal:  Int J Gen Med       Date:  2021-02-23

8.  Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN).

Authors:  F Braido; N Scichilone; F Lavorini; O S Usmani; L Dubuske; L P Boulet; R Mosges; C Nunes; M Sánchez-Borges; I J Ansotegui; M Ebisawa; F Levi-Schaffer; L J Rosenwasser; J Bousquet; T Zuberbier; G Walter Canonica
Journal:  Asthma Res Pract       Date:  2016-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.